{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:13:47Z","timestamp":1792059227487,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.purol.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T20:34:24Z","timestamp":1612902864000},"page":"430-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Injections intrad\u00e9trusorienne de toxine botulique A (onabotuliniumtoxin A) pour traiter l\u2019incontinence urinaire par urgenturie au cours de la maladie de parkinson idiopathique"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-2406","authenticated-orcid":false,"given":"A.","family":"Atamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3282-4229","authenticated-orcid":false,"given":"P.C.","family":"Sichez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5445-4791","authenticated-orcid":false,"given":"F.","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Bandelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gaillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lechevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-3332","authenticated-orcid":false,"given":"G.","family":"Karsenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.purol.2021.01.004_bib0110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015","volume":"16","author":"Feigin","year":"2017","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.purol.2021.01.004_bib0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/aje\/kwr081","article-title":"Prediction model of Parkinson's disease based on antiparkinsonian drug claims","volume":"174","author":"Moisan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.purol.2021.01.004_bib0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrurol.2016.254","article-title":"Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy","volume":"14","author":"Ogawa","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.purol.2021.01.004_bib0125","series-title":"Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People [Internet]","author":"Bennett","year":"2009"},{"issue":"3","key":"10.1016\/j.purol.2021.01.004_bib0130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","article-title":"Bladder and bowel dysfunction in Parkinson's disease","volume":"115","author":"Sakakibara","year":"2008","journal-title":"J Neural Transm Vienna Austria"},{"issue":"5","key":"10.1016\/j.purol.2021.01.004_bib0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.purol.2012.12.004","article-title":"Troubles v\u00e9sicosphinct\u00e9riens des syndromes parkinsoniens\u00a0: une revue du comit\u00e9 de neuro-urologie de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"23","author":"Ph\u00e9","year":"2013","journal-title":"Prog En Urol"},{"issue":"2","key":"10.1016\/j.purol.2021.01.004_bib0140","first-page":"93","article-title":"Urinary symptoms and urodynamic findings in Parkinson's disease","volume":"22","author":"Barrero","year":"2007","journal-title":"Neurol Barc Spain"},{"issue":"2","key":"10.1016\/j.purol.2021.01.004_bib0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.clinthera.2005.02.014","article-title":"Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly","volume":"27","author":"Scheife","year":"2005","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.purol.2021.01.004_bib0150","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/00912700122010528","article-title":"Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system","volume":"41","author":"Todorova","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.purol.2021.01.004_bib0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.purol.2021.01.004_bib0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.purol.2013.11.016","article-title":"Recommandations concernant l\u2019incontinence urinaire de la personne \u00e2g\u00e9e\u00a0: construction et validation de l\u2019algorithme d\u00e9cisionnel GRAPPPA","volume":"24","author":"Amarenco","year":"2014","journal-title":"Prog En Urol"},{"issue":"1","key":"10.1016\/j.purol.2021.01.004_bib0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/nau.20593","article-title":"Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease","volume":"28","author":"Kabay","year":"2009","journal-title":"Neurourol Urodyn."},{"key":"10.1016\/j.purol.2021.01.004_bib0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.urology.2015.09.026","article-title":"The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's Disease","volume":"87","author":"Kabay","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.purol.2021.01.004_bib0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.purol.2021.01.004_bib0180","doi-asserted-by":"crossref","first-page":"e657","DOI":"10.1212\/WNL.0000000000005991","article-title":"Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS","volume":"91","author":"Tullman","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.purol.2021.01.004_bib0185","article-title":"Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson's disease","volume":"16","author":"Kn\u00fcpfer","year":"2016","journal-title":"BMC Urol [Internet]"},{"issue":"1","key":"10.1016\/j.purol.2021.01.004_bib0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2013.09.017","article-title":"OnabotulinumtoxinA office treatment for neurogenic bladder incontinence in Parkinson's Disease","volume":"83","author":"Anderson","year":"2014","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.purol.2021.01.004_bib0195","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons's disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.purol.2021.01.004_bib0200","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"In patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.purol.2021.01.004_bib0205","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/nau.23717","article-title":"Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease","volume":"37","author":"Vurture","year":"2018","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.purol.2021.01.004_bib0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708721000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708721000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:34:28Z","timestamp":1761114868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708721000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1166708721000051"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2021.01.004","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injections intrad\u00e9trusorienne de toxine botulique A (onabotuliniumtoxin A) pour traiter l\u2019incontinence urinaire par urgenturie au cours de la maladie de parkinson idiopathique","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}